F10 and atrial fibrillation: 23.98% of patients with PIP had antithrombotic agents with concurrent significant bleeding risk, while 4.56% had aspirin prescribed in combination with vitamin K antagonists, direct thrombin inhibitors or factor Xa inhibitors in patients with chronic atrial fibrillation.